BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34589490)

  • 1. Uncovering the Association Between m
    Gu X; Zhou H; Chu Q; Zheng Q; Wang J; Zhu H
    Front Cell Dev Biol; 2021; 9():727935. PubMed ID: 34589490
    [No Abstract]   [Full Text] [Related]  

  • 2. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.
    Shen S; Yan J; Zhang Y; Dong Z; Xing J; He Y
    Ann Transl Med; 2021 Jan; 9(1):59. PubMed ID: 33553352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma.
    Liu Y; Zheng S; Wang T; Fang Z; Kong J; Liu J
    Front Cell Dev Biol; 2022; 10():842220. PubMed ID: 35252205
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of m
    Wang X; Mao Y; Xu H; Chen J; Chen X
    Heliyon; 2023 Sep; 9(9):e19680. PubMed ID: 37809908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
    Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
    Front Immunol; 2022; 13():914577. PubMed ID: 35757739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
    Zhao M; Shen S; Xue C
    Front Immunol; 2022; 13():805967. PubMed ID: 35401564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Wen Q; Wang S; Hong L; Shen S; He Y; Sheng X; Zhuang X; Chen S; Wang Y; Zhuang H
    Immun Inflamm Dis; 2024 Jan; 12(1):e1150. PubMed ID: 38270308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma.
    Liu DL; Wu MY; Zhang TN; Wang CG
    Front Mol Biosci; 2022; 9():807502. PubMed ID: 35155577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming.
    Yan D; Xie Y; Huang L; Zhang Y; Gu R; Xie H; Huang X; Luo H
    J Cell Mol Med; 2023 Aug; 27(16):2398-2411. PubMed ID: 37408139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma.
    Xing J; Shen S; Dong Z; Hu X; Xu L; Liu X; Li Q; Zhang Y; Cui G; Yu Z
    Front Cell Dev Biol; 2021; 9():761391. PubMed ID: 34858985
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Fan Y; Zhou Y; Lou M; Li X; Zhu X; Yuan K
    J Inflamm Res; 2022; 15():1969-1989. PubMed ID: 35356071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
    Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
    Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA m
    Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
    Front Immunol; 2022; 13():905057. PubMed ID: 36389669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Molecular Characterization of m
    Zhu J; Xiao J; Wang M; Hu D
    Front Oncol; 2020; 10():618374. PubMed ID: 33585244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
    Yang X; Yang F; Lan L; Wen N; Li H; Sun X
    Front Genet; 2022; 13():972043. PubMed ID: 36105093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.